Notably, miR-193a-5p’s interaction with the tumor immune microenvironment reveals novel therapeutic dimensions: Its regulation of immune checkpoint molecules (e.g., PD-L1) may influence T-cell infiltration (62), while exosome-mediated intercellular communication could reshape immunosuppressive microenvironments (63), providing rationale for combination immunotherapy. Here, CD274 is linked to neoplasm.